These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 9739042)

  • 1. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor alpha- deficient mice.
    Djouadi F; Weinheimer CJ; Saffitz JE; Pitchford C; Bastin J; Gonzalez FJ; Kelly DP
    J Clin Invest; 1998 Sep; 102(6):1083-91. PubMed ID: 9739042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders.
    Leone TC; Weinheimer CJ; Kelly DP
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7473-8. PubMed ID: 10377439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.
    Kersten S; Seydoux J; Peters JM; Gonzalez FJ; Desvergne B; Wahli W
    J Clin Invest; 1999 Jun; 103(11):1489-98. PubMed ID: 10359558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic de novo synthesis of glucose 6-phosphate is not affected in peroxisome proliferator-activated receptor alpha-deficient mice but is preferentially directed toward hepatic glycogen stores after a short term fast.
    Bandsma RH; Van Dijk TH; Harmsel At At; Kok T; Reijngoud DJ; Staels B; Kuipers F
    J Biol Chem; 2004 Mar; 279(10):8930-7. PubMed ID: 14688286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha.
    Brandt JM; Djouadi F; Kelly DP
    J Biol Chem; 1998 Sep; 273(37):23786-92. PubMed ID: 9726988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the peroxisome proliferator-activated receptor alpha (PPAR alpha) in the control of cardiac lipid metabolism.
    Djouadi F; Brandt JM; Weinheimer CJ; Leone TC; Gonzalez FJ; Kelly DP
    Prostaglandins Leukot Essent Fatty Acids; 1999; 60(5-6):339-43. PubMed ID: 10471118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype of peroxisome proliferator-activated receptor-alpha(PPARalpha)deficient mice on mixed background fed high fat diet.
    Kim BH; Won YS; Kim EY; Yoon M; Nam KT; Oh GT; Kim DY
    J Vet Sci; 2003 Dec; 4(3):239-44. PubMed ID: 14685029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin.
    Sugden MC; Bulmer K; Gibbons GF; Knight BL; Holness MJ
    Biochem J; 2002 Jun; 364(Pt 2):361-8. PubMed ID: 12023878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting.
    Hashimoto T; Cook WS; Qi C; Yeldandi AV; Reddy JK; Rao MS
    J Biol Chem; 2000 Sep; 275(37):28918-28. PubMed ID: 10844002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mutant thyroid hormone receptor alpha antagonizes peroxisome proliferator-activated receptor alpha signaling in vivo and impairs fatty acid oxidation.
    Liu YY; Heymann RS; Moatamed F; Schultz JJ; Sobel D; Brent GA
    Endocrinology; 2007 Mar; 148(3):1206-17. PubMed ID: 17122078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity.
    Watanabe K; Fujii H; Takahashi T; Kodama M; Aizawa Y; Ohta Y; Ono T; Hasegawa G; Naito M; Nakajima T; Kamijo Y; Gonzalez FJ; Aoyama T
    J Biol Chem; 2000 Jul; 275(29):22293-9. PubMed ID: 10801788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
    Aasum E; Cooper M; Severson DL; Larsen TS
    Can J Physiol Pharmacol; 2005 Feb; 83(2):183-90. PubMed ID: 15791292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic islet adaptation to fasting is dependent on peroxisome proliferator-activated receptor alpha transcriptional up-regulation of fatty acid oxidation.
    Gremlich S; Nolan C; Roduit R; Burcelin R; Peyot ML; Delghingaro-Augusto V; Desvergne B; Michalik L; Prentki M; Wahli W
    Endocrinology; 2005 Jan; 146(1):375-82. PubMed ID: 15459119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of PPAR alpha as a "lipostat" transcription factor.
    Djouadi F; Weinheimer CJ; Kelly DP
    Adv Exp Med Biol; 1999; 466():211-20. PubMed ID: 10709647
    [No Abstract]   [Full Text] [Related]  

  • 15. Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha.
    Cook WS; Yeldandi AV; Rao MS; Hashimoto T; Reddy JK
    Biochem Biophys Res Commun; 2000 Nov; 278(1):250-7. PubMed ID: 11071880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production.
    Xu J; Xiao G; Trujillo C; Chang V; Blanco L; Joseph SB; Bassilian S; Saad MF; Tontonoz P; Lee WN; Kurland IJ
    J Biol Chem; 2002 Dec; 277(52):50237-44. PubMed ID: 12176975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone.
    Holness MJ; Bulmer K; Smith ND; Sugden MC
    Biochem J; 2003 Feb; 369(Pt 3):687-95. PubMed ID: 12435272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
    Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
    Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus.
    Finck BN; Lehman JJ; Leone TC; Welch MJ; Bennett MJ; Kovacs A; Han X; Gross RW; Kozak R; Lopaschuk GD; Kelly DP
    J Clin Invest; 2002 Jan; 109(1):121-30. PubMed ID: 11781357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPAR signaling in the control of cardiac energy metabolism.
    Barger PM; Kelly DP
    Trends Cardiovasc Med; 2000 Aug; 10(6):238-45. PubMed ID: 11282301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.